Post-approval studies (Phase 4)Study completedNCT03030235
What this trial is testing
Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
Who this might be right for
Chronic Heart Failure With Preserved Systolic Function
Saint Luke's Health System 324